台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

佳醫

(4104)
可現股當沖
  • 股價
    91.3
  • 漲跌
    ▲0.6
  • 漲幅
    +0.66%
  • 成交量
    125
  • 產業
    上市 生技醫療類股
  • 331人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
佳醫 (4104)籌碼相關-香港上海匯豐 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

香港上海匯豐 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/0900.001391.9191.90-13294-4.41%
2024/05/0800.00992.0091.80-9294-3.06%
2024/04/2200.007.490.1990.50-7.4282-2.62%
2024/03/0400.0011.890.3790.30-11.8159-7.43%
2024/03/0100.00790.8391.20-7153-4.57%
2024/01/1700.00286.2086.00-2143-1.39%
2023/12/15288.4500.0088.4021601.25%
2023/11/0800.003.287.3787.50-3.2164-1.92%
2023/09/2500.002289.3589.30-22361-6.09%
2023/08/2300.001.889.8989.90-1.8554-0.32%
2023/07/2500.0025.892.1092.00-25.8723-3.56%
2023/07/21194.3000.0093.9017110.14%
2023/07/19296.8000.0095.4027000.29%
2023/07/05199.2000.0099.2016700.15%
2023/06/2900.003798.22100.00-37602-6.14%
2023/06/2700.007293.1993.40-72552-13.04%
2023/06/012391.3900.0091.60235624.09%
2023/05/3000.001990.7890.80-19568-3.34%
2023/05/2400.001692.3992.90-16590-2.71%
2023/04/121881.5100.0081.50184683.84%
2023/01/312371.4300.0071.00232818.18%
2023/01/091468.1800.0068.30142555.48%
2022/12/132866.3500.0065.702820713.52%
2022/12/082164.6400.0064.802119710.63%
2022/09/2700.00964.4764.80-9229-3.92%
2022/05/2300.002166.7866.70-21504-4.16%
2022/05/062067.6600.0067.90204904.08%
2021/10/2000.00155.0055.10-1146-0.68%
2021/08/302155.5600.0055.702120210.37%
2021/05/20656.2000.0056.2063181.88%
2021/04/1400.0016.158.1658.10-16.1251-6.42%
2021/02/23155.9000.0056.2012200.45%
2020/06/2200.009058.8158.70-90495-18.16%
2020/04/30153.9000.0053.9012920.34%
2020/03/2600.00149.7550.40-1306-0.33%
2020/03/2000.00148.8048.80-1304-0.33%
2020/02/1200.004452.8952.90-44256-17.14%
2020/02/1100.001252.9052.90-12268-4.47%
2019/09/201653.3800.0053.30164083.91%
2019/07/192055.4300.0054.90202687.45%
2019/07/16753.5300.0053.6072133.29%
2019/07/153352.8900.0052.803320216.29%
2019/01/1100.001547.1047.15-15129-11.57%
2018/11/2900.001745.5145.50-17166-10.18%
2018/11/1400.001645.2845.35-16170-9.39%
2018/02/2700.002944.9144.90-29247-11.73%
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音